WASHINGTON, Sept. 25 (UPI) -- The U.S. National Institute of Allergy and Infectious Diseases has announced five awards totaling $4 million to fund a study of anti-radiation treatments.
Officials said the grants from the NIAID, part of the National Institutes of Health, will aid in the development of products that can eliminate radioactive materials from the human body following radiological or nuclear exposure.
"These new grants will help identify new drug candidates that could be acquired by the strategic national stockpile of medical countermeasures, which is available to the public after a terrorist or nuclear attack or accidental radioactive exposure," said NIAID Director Dr. Anthony Fauci.
The grants announced Monday:
-- Raymond Bergeron, University of Florida-Gainesville, $1 million.
-- Tatiana Levitskaia, Pacific Northwest National Laboratory, Richland, Wash., $725,000.
-- Scott C. Miller, University of Utah School of Medicine, Salt Lake City, $675,000.
-- Kenneth Raymond, University of California-Lawrence Berkeley National Laboratory, Berkeley, Calif., $998,325.
-- Charles Timchalk, Pacific Northwest National Laboratory, Richland, Wash., $599,747.